Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical intervention

Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

Object

The goal in this article was to compare 0.1 mmol/kg doses of gadobenate dimeglumine (Gd-BOPTA) and gadopentetate dimeglumine, also known as gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA), for enhanced magnetic resonance (MR) imaging of intraaxial brain tumors.

Methods

Eighty-four patients with either intraaxial glioma (47 patients) or metastasis (37 patients) underwent two MR imaging examinations at 1.5 tesla, one with Gd-BOPTA as the contrast agent and the other with Gd-DTPA. The interval between fully randomized contrast medium administrations was 2 to 7 days. The T1-weighted spin echo and T2-weighted fast spin echo images were acquired before administration of contrast agents and T1-weighted spin echo images were obtained after the agents were administered. Acquisition parameters and postinjection acquisition times were identical for the two examinations in each patient. Three experienced readers working in a fully blinded fashion independently evaluated all images for degree and quality of available information (lesion contrast enhancement, lesion border delineation, definition of disease extent, visualization of the lesion's internal structures, global diagnostic preference) and quantitative enhancement (that is, the extent of lesion enhancement after contrast agent administration compared with that seen before its administration [hereafter referred to as percent enhancement], lesion/brain ratio, and contrast/noise ratio). Differences were tested with the Wilcoxon signed-rank test. Reader agreement was assessed using kappa statistics.

Significantly better diagnostic information/imaging performance (p < 0.0001, all readers) was obtained with Gd-BOPTA for all visualization end points. Global preference for images obtained with Gd-BOPTA was expressed for 42 (50%), 52 (61.9%), and 56 (66.7%) of 84 patients (readers 1, 2, and 3, respectively) compared with images obtained with Gd-DTPA contrast in four (4.8%), six (7.1%), and three (3.6%) of 84 patients. Similar differences were noted for all other visualization end points. Significantly greater quantitative contrast enhancement (p < 0.04) was noted after administration of Gd-BOPTA. Reader agreement was good (κ > 0.4).

Conclusions

Lesion visualization, delineation, definition, and contrast enhancement are significantly better after administration of 0.1 mmol/kg Gd-BOPTA, potentially allowing better surgical planning and follow up and improved disease management.

Abbreviations used in this paper:BBB = blood–brain barrier; CNR = contrast/noise ratio; CNS = central nervous system; FOV = field of view; Gd-BOPTA = gadobenate dimeglumine; Gd-DTPA = gadolinium diethylenetriamine pentaacetic acid; LBR = lesion/brain ratio; MR = magnetic resonance; ROI = region of interest.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Address reprint requests to: Matthew J. Kuhn, M.D., Department of Radiology, Southern Illinois University School of Medicine, 800 East Carpenter Street, Springfield, Illinois 62769. email: mkuhn@st-johns.org.
  • 1

    Albert FK, , Forsting M, , Sartor K, , Adams HP, & Kunze S: Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34:4561, 1994

    • Search Google Scholar
    • Export Citation
  • 2

    Ausman JI: Is intraoperative MR-guided surgery of value?. Surg Neurol 56:276, 2001

  • 3

    Banci L, , Bertini I, & Luchinat C: Nuclear and Electron Relaxation Weinheim, Germany, VCH Verlagsgesellschaft, 1991. 138

  • 4

    Berger MS: Malignant astrocytomas: surgical aspects. Semin Oncol 21:172185, 1994

  • 5

    Cavagna FM, , Maggioni F, , Castelli PM, , Dapra M, , Imperatori LG, & Lorusso V, : Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 32:780796, 1997

    • Search Google Scholar
    • Export Citation
  • 6

    Ciric I, , Vick NA, , Mikhael MA, , Cozzens J, , Eller T, & Walsh A: Aggressive surgery for malignant supratentorial gliomas. Clin Neurosurg 36:375383, 1990

    • Search Google Scholar
    • Export Citation
  • 7

    Colosimo C, , Demaerel P, , Tortori-Donati P, , Christophe C, , Van Buchem M, & Hogstrom B, : Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumors in children. Pediatr Radiol 35:501510, 2005

    • Search Google Scholar
    • Export Citation
  • 8

    Colosimo C, , Knopp MV, , Barreau X, , Gerardin E, , Kirchin MA, & Guezenoc F, : A comparison of Gd-BOPTA and Gd-DOTA for contrast-enhanced MRI of intracranial tumors. Neuroradiology 46:655665, 2004

    • Search Google Scholar
    • Export Citation
  • 9

    Criteria Committee of the American Heart Association: Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels ed 9 New York, Little, Brown, 1994

    • Search Google Scholar
    • Export Citation
  • 10

    de Haen C, , Cabrini M, , Akhnana L, , Ratti D, , Calabi L, & Gozzini L: Gadobenate dimeglumine 0.5 M solution for injection (Multi-Hance) pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium. J Comput Assist Tomogr 23:1 Suppl S161S168, 1999

    • Search Google Scholar
    • Export Citation
  • 11

    de Haën C, & Gozzini L: Soluble-type hepatobiliary contrast agents for MR imaging. J Magn Reson Imaging 3:179186, 1993

  • 12

    Ekinci G, , Akpinar IN, , Baltacioglu F, , Erzen C, , Kilic T, & Elmaci I, : Early-postoperative magnetic resonance imaging in glial tumors: prediction of tumor regrowth and recurrence. Eur J Radiol 45:99107, 2003

    • Search Google Scholar
    • Export Citation
  • 13

    Essig M, , Tartaro A, , Tartaglione T, , Pirovano G, , Kirchin MA, & Spinazzi A: Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators. Acad Radiol 13:744751, 2006

    • Search Google Scholar
    • Export Citation
  • 14

    Ewend MG, , Elbabaa S, & Carey LA: Current treatment paradigms for the management of patients with brain metastases. Neurosurgery 57:5 Suppl S66S77, 2005

    • Search Google Scholar
    • Export Citation
  • 15

    Fleiss JL: The Design and Analysis of Clinical Experiments New York, NY, John Wiley & Sons, Inc, 1999. Chapter 3 7678

  • 16

    Fleiss JL: Statistical Methods for Rates and Proportions ed 2 New York, NY, John Wiley & Sons, 1981

  • 17

    Floeth FW, , Pauleit D, , Wittsack HJ, , Langen KJ, , Reifenberger G, & Hamacher K, : Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy. J Neurosurg 102:318327, 2005

    • Search Google Scholar
    • Export Citation
  • 18

    Greco A, , Parker JR, , Ratcliffe CG, , Kirchin MA, & McNamara MT: Phase III, randomized, double-blind, cross-over comparison of gadoteridol and gadopentetate dimeglumine in magnetic resonance imaging of patients with intracranial lesions. Australas Radiol 45:457463, 2001

    • Search Google Scholar
    • Export Citation
  • 19

    Grossman RI, , Rubin DL, , Hunter G, , Haughton VM, , Lee D, & Sze G, : Magnetic resonance imaging in patients with central nervous system pathology: a comparison of OptiMARK (Gd-DTPA-BMEA) and Magnevist (Gd-DTPA). Invest Radiol 35:412419, 2000

    • Search Google Scholar
    • Export Citation
  • 20

    Healy ME, , Hesselink JR, , Press GA, & Middleton MS: Increased detection of intracranial metastases with intravenous Gd-DTPA. Radiology 165:619624, 1987

    • Search Google Scholar
    • Export Citation
  • 21

    Johnson PC, , Hunt SJ, & Drayer BP: Human cerebral gliomas: correlation of postmortem MR imaging and neuropathologic findings. Radiology 170:211217, 1989

    • Search Google Scholar
    • Export Citation
  • 22

    Jolesz FA, , Talos IF, , Schwartz RB, , Mamata H, , Kacher DF, & Hynynen K, : Intraoperative magnetic resonance imaging and magnetic resonance imaging-guided therapy for brain tumors. Neuroimaging Clin N Am 12:665683, 2002

    • Search Google Scholar
    • Export Citation
  • 23

    Kaal EC, , Niel CG, & Vecht CJ: Therapeutic management of brain metastasis. Lancet Neurol 4:289298, 2005

  • 24

    Kaal EC, , Taphoorn MJ, & Vecht CJ: Symptomatic management and imaging of brain metastases. J Neurooncol 75:1520, 2005

  • 25

    Kirchin MA, , Pirovano G, , Venetianer C, & Spinazzi A: Safety assessment of gadobenate dimeglumine (Multihance): extended clinical experience from phase I studies to post-marketing surveillance. J Magn Reson Imaging 14:281294, 2001

    • Search Google Scholar
    • Export Citation
  • 26

    Kirchin MA, & Runge VM: Contrast agents for magnetic resonance imaging: safety update. Top Magn Reson Imaging 14:426435, 2003

  • 27

    Knauth M, , Wirtz CR, , Tronnier VM, , Aras N, , Kunze S, & Sartor K: Intraoperative MR imaging increases the extent of tumor resection in patients with high-grade gliomas. AJNR Am J Neuroradiol 20:16421646, 1999

    • Search Google Scholar
    • Export Citation
  • 28

    Knopp EA, , Cha S, , Johnson G, , Mazumdar A, , Golfinos JG, & Zagzag D, : Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 211:791798, 1999

    • Search Google Scholar
    • Export Citation
  • 29

    Knopp MV, , Runge VM, , Essig M, , Hartman M, , Jansen O, & Kirchin MA, : Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Radiology 230:5564, 2004

    • Search Google Scholar
    • Export Citation
  • 30

    Kondziolka D, , Patel A, , Lunsford LD, , Kassam A, & Flickinger JC: Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 45:427434, 1999

    • Search Google Scholar
    • Export Citation
  • 31

    Law M: MR spectroscopy of brain tumors. Top Magn Reson Imaging 15:291313, 2004

  • 32

    Laws ER, , Parney IF, , Huang W, , Anderson F, , Morris AM, & Asher A, : Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 99:467473, 2003

    • Search Google Scholar
    • Export Citation
  • 33

    Levin VA, , Hoffman WF, , Heilbron DC, & Norman D: Prognostic significance of the pretreatment CT scan on time to progression for patients with malignant gliomas. J Neurosurg 52:642647, 1980

    • Search Google Scholar
    • Export Citation
  • 34

    Maley JE, & Yuh WTC: Contrast dosage in the neuroimaging of brain tumors. Principles and indications. Magn Reson Imaging Clin N Am 6:113124, 1998

    • Search Google Scholar
    • Export Citation
  • 35

    Maravilla KR, , Maldjian JA, , Schmalfuss IM, , Kuhn MJ, , Bowen BC, & Wippold FJ II, : Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two MR contrast agents. Radiology 240:389400, 2006

    • Search Google Scholar
    • Export Citation
  • 36

    Martin AJ, , Hall WA, , Liu H, , Pozza CH, , Michel E, & Casey SO, : Brain tumor resection: intraoperative monitoring with high-field-strength MR imaging—initial results. Radiology 215:221228, 2000

    • Search Google Scholar
    • Export Citation
  • 37

    McDermott MW, & Sneed PK: Radiosurgery in metastatic brain cancer. Neurosurgery 57:5 Suppl S45S54, 2005

  • 38

    Myhr G, , Rinck PA, & Børseth A: Gadodiamide injection and gado-pentetate dimeglumine: a double-blind study in MR imaging of the CNS. Acta Radiol 33:405409, 1992

    • Search Google Scholar
    • Export Citation
  • 39

    Nimsky C, , Ganslandt O, , Buchfelder M, & Fahlbusch R: Glioma surgery evaluated by intraoperative low-field magnetic resonance imaging. Acta Neurochir Suppl 85:5563, 2003

    • Search Google Scholar
    • Export Citation
  • 40

    Nimsky C, , Ganslandt O, & Fahlbusch R: Comparing 0.2 tesla with 1.5 tesla intraoperative magnetic resonance imaging analysis of setup, workflow, and efficiency. Acad Radiol 12:10651079, 2005

    • Search Google Scholar
    • Export Citation
  • 41

    Nimsky C, , Ganslandt O, & Fahlbusch R: 1.5 T: intraoperative imaging beyond standard anatomic imaging. Neurosurg Clin N Am 16:185200, 2005

    • Search Google Scholar
    • Export Citation
  • 42

    Nimsky C, , Ganslandt O, , Von Keller B, , Romstock J, & Fahlbusch R: Intraoperative high-field-strength MR imaging: implementation and experience in 200 patients. Radiology 233:6778, 2004

    • Search Google Scholar
    • Export Citation
  • 43

    Oh DS, & Black PM: A low-field intraoperative MRI system for glioma surgery: is it worthwhile?. Neurosurg Clin N Am 16:135141, 2005

  • 44

    Oh J, , Cha S, , Aiken AH, , Han ET, , Crane JC, & Stainsby JA, : Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema. J Magn Reson Imaging 21:701708, 2005

    • Search Google Scholar
    • Export Citation
  • 45

    Oudkerk M, , Sijens PE, , Van Beek EJ, & Kuijpers TJ: Safety and efficacy of dotarem (Gd-DOTA) versus magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system. Invest Radiol 30:7578, 1995

    • Search Google Scholar
    • Export Citation
  • 46

    Paek SH, , Audu PB, , Sperling MR, , Cho J, & Andrews DW: Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Neurosurgery 56:10211034, 2005

    • Search Google Scholar
    • Export Citation
  • 47

    Patchell RA, , Tibbs PA, , Regine WF, , Dempsey RJ, , Mohiuddin M, & Kryscio RJ, : Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280:14851489, 1998

    • Search Google Scholar
    • Export Citation
  • 48

    Pintaske J, , Martirosian P, , Graf H, , Erb G, , Lodemann KP, & Claussen CD, : Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist), and gadobenate dimeglumine (Multi-Hance) in human blood plasma at 0.2, 1.5, and 3 Tesla. Invest Radiol 41:213221, 2006

    • Search Google Scholar
    • Export Citation
  • 49

    Rollin N, , Guyotat J, , Streichenberger N, , Honnorat J, , Tran Minh VA, & Cotton F: Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intraaxial brain tumors. Neuroradiology 48:150159, 2006

    • Search Google Scholar
    • Export Citation
  • 50

    Salcman M, , Levine H, & Rao K: Value of sequential computed tomography in the multimodality treatment of glioblastoma multiforme. Neurosurgery 8:1519, 1981

    • Search Google Scholar
    • Export Citation
  • 51

    Schwartz KM, , Erickson BJ, & Lucchinetti C: Pattern of T2 hypointensity associated with ring-enhancing brain lesions can help to differentiate pathology. Neuroradiology 48:143149, 2006

    • Search Google Scholar
    • Export Citation
  • 52

    Seitz RJ, & Wechsler W: Immunohistochemical demonstration of serum proteins in human cerebral gliomas. Acta Neuropathol (Berl) 73:145152, 1987

    • Search Google Scholar
    • Export Citation
  • 53

    Shellock FG, , Parker JR, , Venetianer C, , Pirovano G, & Spinazzi A: Safety of gadobenate dimeglumine: summary of findings from clinical studies and post-marketing surveillance. Invest Radiol 41:500509, 2006

    • Search Google Scholar
    • Export Citation
  • 54

    Spinazzi A, , Lorusso V, , Pirovano G, & Kirchin M: Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers. Acad Radiol 6:282291, 1999

    • Search Google Scholar
    • Export Citation
  • 55

    Valk J, , Algra PR, , Hazenberg CJ, , Slooff WBM, & Slavand MG: A double-blind, comparative study of gadodiamide injection and gadopentetate dimeglumine in MRI of the central nervous system. Neuroradiology 35:173177, 1993

    • Search Google Scholar
    • Export Citation
  • 56

    Warmuth-Metz M: Postoperative imaging after brain tumor resection. Acta Neurochir Suppl 88:1320, 2003

  • 57

    Yuh WT, , Fisher DJ, , Engelken JD, , Greene GM, , Sato Y, & Ryals TJ, : MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol. Radiology 180:485491, 1991

    • Search Google Scholar
    • Export Citation
  • 58

    Yuh WTC, , Engelken JD, , Muhonen MG, , Mayr NA, , Fisher DJ, & Ehrhardt JC: Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases. AJNR Am J Neuroradiol 13:335345, 1992

    • Search Google Scholar
    • Export Citation
  • 59

    Yuh WTC, , Halloran JI, , Mayr NA, , Fisher DJ, , Nguyen HD, & Simonson TM: Dose of contrast material in the MR imaging evaluation of central nervous system tumors. J Magn Reson Imaging 4:242249, 1994

    • Search Google Scholar
    • Export Citation
  • 60

    Yuh WTC, , Tali ET, , Nguyen HD, , Simonson TM, , Mayr NA, & Fisher DJ: The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis. AJNR Am J Neuroradiol 16:373380, 1995

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 512 147 6
Full Text Views 179 5 0
PDF Downloads 116 4 0
EPUB Downloads 0 0 0